Evidence map›Paper›PMID 33981170›Full record

ReviewJournal of blood medicine2021

Primary Pancreatic Lymphoma: Recommendations for Diagnosis and Management.

Davide Facchinelli, Enrico Boninsegna, Carlo Visco, Cristina Tecchio

Open access · goldAbstract readReview
In one paragraph

Review in Journal of blood medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Imaging of non-ductal pancreatic neoplasms.Abdominal radiology (New York) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Differential Diagnosis of Pancreatic Cancer and its Mimicking Lesions.Journal of the Korean Society of Radiology · 2024
    Review
  9. Primary pancreatic peripheral T-cell lymphoma: A case report.World journal of gastrointestinal oncology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in medicine · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. A Rare Case of Primary B-Cell Lymphoma of the Pancreas.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Davide FacchinelliHematology Unit, Ospedale San Bortolo, Vicenza, Italy.
Enrico BoninsegnaDepartment of Radiology, Azienda Socio Sanitaria Territoriale, Mantova, Italy.
Carlo ViscoHematology and Bone Marrow Transplant Unit, Department of Medicine, University of Verona, Verona, Italy.
Cristina TecchioHematology and Bone Marrow Transplant Unit, Department of Medicine, University of Verona, Verona, Italy.
University of Verona · ITAzienda Socio Sanitaria Territoriale Lariana · ITOspedale San Bortolo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary pancreatic lymphoma (PPL) is a rare disease representing 0.1% of all malignant lymphomas, which lacks well-defined diagnostic and therapeutic protocols. We conducted a systematic review to analyze demographic, diagnostic and therapeutic features of PPL.

methodsThis review identified small series and single case reports. Sources were MEDLINE, PubMed, and the Cochrane library from January 2001 to December 2020. Data were screened, extracted and the risk of bias analyzed by three independent reviewers.

resultsA total of 107 eligible papers (17 small series, 90 single case reports) describing 266 patients were identified. Patients had a median age of 53.1 (range 3-86) years and were males in 64.6% of cases. Abdominal pain and jaundice were the most common presenting symptoms, affecting 75.3% and 41.8% of patients, respectively. PPL had a median size of 60.6 mm (range 16-200) and it was localized in the pancreatic head in 63.7% of cases. At diagnosis most patients underwent ultrasonography followed by computed tomography. PPL typically showed low echogenicity, and lower contrast enhancement than solid tumors. Histopathological specimens were obtained by percutaneous or endoscopic biopsies in 47.7% of patients; abdominal surgery was performed in 33.5% of cases. Overall, diffuse large B-cell lymphoma was the most frequent histological diagnosis (53.6%). However, patients aged <18 years were affected by Burkitt lymphoma in 52.4% of cases. Most patients (53.6%) received immunochemotherapy (IC) or IC plus radiotherapy (14%). Demolitive surgery appeared to be associated with impaired survival. Central nervous system (CNS) relapse or progression was observed in 20% of patients.

conclusionPPL is a rare entity, with some peculiar features at modern imaging. For diagnostic purposes percutaneous or endoscopic biopsies might be preferable, as opposed to surgery. No definite data is available about the optimal treatment, which should be tailored on the histological type and associated with CNS prophylaxis.

Indexed as

Burkitt lymphomadiffuse large B cell lymphomaprimary pancreatic lymphoma

Identifiers

PMID33981170
PMCPMC8107008
OpenAlexW3157498124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.